Antiretroviral penetration across three preclinical animal models and humans in eight putative HIV viral reservoirs.
For HIV cure strategies like "kick and kill" to succeed, antiretroviral (ARV) drugs must reach effective concentrations in putative viral reservoirs. We characterize penetration of 6 ARVs in 3 preclinical animal models and humans. We found that standard dosing strategies in preclinical species closely mimicked tissue concentrations in humans for some - but not all - ARVs. These results have implications for interpreting HIV treatment, prevention, or cure interventions between preclinical and clinical models.